Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer, open access.

View Abstract

Snell Taylor SJ, Nielson CM, Breskin A, Saul B, Yu Y, Alam N, … Kelsh M, et al. 2021. Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic immune thrombocytopenia in European clinical practice. Adv Ther 38(5):2673–2688.

View Abstract

McGrath LJ, Nielson C, Saul B, Breskin A, Yu Y, Nicolaisen SK, … Kelsh M, et al. 2021. Lessons learned using real-world data to emulate randomized trials: A case study of treatment effectiveness for newly diagnosed immune thrombocytopenia. Clin Pharmacol Ther 110(6):1570–1578. doi: 10.1002/cpt.2399.

View Abstract

Catlin NR, Cappon GD, Engel S, Rohde CM, Nowland WS, Buitrago S, et al. 2021. Maternal Immunization with Group B streptococcus 6-valent polysaccharide conjugate vaccine supported by lack of toxicity in rat and rabbit fertility and developmental toxicity studies. Birth Defects Res 113(19):1343–1356, DOI: 10.1002/bdr2.1953, article online.

View Abstract

Haddadin Z, Rankin DA, Lipworth L, Suh M, McHenry R, Blozinski A, Salib George S, Fernandez KN, Varjabedian R, Spieker AJ, Shepard DS, Halasa NB. 2021. Respiratory virus surveillance in infants across different clinical settings. J Pediat, DOI: https://doi.org/10.1016/j.jpeds.2021.03.036.

View Abstract

Vágó EK, Nicholson G, Horváth-Puhó E. Hooda N, Fryzek JP, Su J. 2021. Healthcare resource utilization among patients with cold agglutinin disease in Denmark. Curr Med Res Opin, open access.

View Abstract

Sacks NC, Healey BE, Cyr PL, Slocomb T, James E, Beggs AH, Graham RJ. 2021. Costs and health resource use in patients with X-linked myotubular myopathy: insights from U.S. commercial claims. J Manag Care Spec Pharm 27(8):1019–1026, DOI: 10.18553/jmcp.2021.20501, online article.

View Abstract

Bowman CJ,  Bouressam M, Campion SN, Cappon GD, Catlin NR, Cutler MW, et al. 2021 Lack of effects on female rat fertility and pre/postnatal development with BNT162b2, a mRNA-based COVID-19 vaccine. Reprod Toxicol 103:28–35, DOI: 10.1016/j.reprotox.2021.05.007, open access online

View Abstract

van de Ligt JLG. 2021. Transboundary risks of disease transfer in food and feed supply chains. 82nd Minnesota Nutrition Conference.

Crincoli CM, van de Ligt JLG, Pavel AT, Eapen AK. 2021. A decision tree supporting the use of regulatory frameworks in food ingredient safety: An industry perspective. American College of Toxicology 42nd Annual Meeting.

van de Ligt, Jennifer LG. 2021. Testimony for the Record Submitted to the House Agriculture Committee Subcommittee on Livestock and Foreign Agriculture. Hearing: “State of the Beef Supply Chain: Shocks, Recovery, and Rebuilding.” Retrieved from the US House of Representatives Committee Repository.

View Abstract

Shurson GC, Urriola PE., van de Ligt JLG. 2021. Can we effectively manage parasites, prions, and pathogens in the global feed industry to achieve One Health? Transbound Emerg Dis 69:4–30.

View Abstract

Doepker CD, Heintz MM, van de Ligt JLG, Wikoff DS. 2021. Review of potential risks associated with supplementary dietary exposure to nitrate-containing compounds in swine — A paradox in light of emerging benefits. Trans Anim Sci 5(4):txab203.

View Abstract

van de Ligt JLG, Saddoris-Clemens KL, Norton SA, Davis MD, Doepker CL. 2021. Impact of calcium nitrate supplementation on the oxygen-carrying capacity of lactating sows and their offspring. Trans Anim Sci 5(4):txab217.

View Abstract

East A, Isaacs K, Vallero D. Application of the Residential Population Generator (RPGen) in prediction of exposure outcomes for owners and renters from consumer products using the Combined Human Exposure Model (CHEM). Symposium presented at International Society of Exposure Science Annual Meeting, virtual conference, September 2021, DOI: 10.23645/epacomptox.16632319, open access online.

View Abstract

East A, Brady S, Isaacs K, Vallero D. The role of the Product Use Scheduler (PUS) in determining product use categories (PUCs) for owners and renters in the Combined Human Exposure Model (CHEM). Symposium presented at International Society of Exposure Science Annual Meeting, virtual conference, September 2021. DOI: 10.23645/epacomptox.16632271, open access online.

View Abstract

Fisher H, East A, Vallero D. Estimating longitudinal aggregate exposure — The third module of CHEM: Source to dose. Symposium presented at International Society of Exposure Science Annual Meeting, virtual conference, September 2021, DOI: 10.23645/epacomptox.16630675, open access online.

View Abstract

East A, Dawson D, Glen G, Isaacs K, Dionisio K, Price PS, et al. 2021. The Residential Population Generator (RPGen): Parameterization of residential, demographic, and physiological data to model intraindividual exposure, dose, and risk. Toxics 9(11):303, DOI: 10.3390/toxics9110303, open access online.

View Abstract

East A, Egeghy PP, Cohen Hubal EA, Slover R, Vallero DA. 2021. Computational estimates of daily aggregate exposure to PFOA/PFOS from 2011 to 2017 using a basic intake model. J Expos Sci Environ Epidemiol, DOI:10.1038/s41370-021-00374-w, open access online.

View Abstract

Wikoff D, Fitch S, Borghoff S. Case-study applications using evidence-based approaches to assess endocrine activity for risk assessment. Invited speaker (Wikoff):  61st Annual Meeting (virtual) of the Society for Birth Defects Research & Prevention, June 2021.

View Abstract